By Connor Hart
Ginkgo Bioworks promoted its chief accounting officer, Steven Coen, to its top finance role.
Coen will succeed Mark Dmytruk, who intends to resign from his role at the biotech company on May 30 to accept a position at another organization, it said Wednesday.
Coen, who is 59 years old, has more than 30 years of public accounting and corporate finance leadership experience, according to Ginkgo.
Prior to joining the company in 2023, he served as corporate controller for Charles River Laboratories. Coen previously held accounting and finance roles in the technology and medical-device industries, and spent more than 17 years in the audit practice at Deloitte & Touche.
As CFO, Coen will receive an annual base salary of $460,000, according to a filing with the Securities and Exchange Commission. He will additionally receive a performance-based restricted stock units award for nearly 68,000 shares of the company's Class A common stock.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
May 21, 2025 17:08 ET (21:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。